- Europe's medicines regulator said on Wednesday it would restrict experts and committee members who intend to work for a pharmaceutical company from participating in the evaluation of medicines, in a move to reduce conflict of interests.
- Drugmaker Alexion Pharmaceuticals Inc said it would buy Synageva BioPharma Corp for $8.4 billion to gain access to its experimental early-stage treatment for a rare metabolic disease.
LONDON - Europe will face an obesity crisis of vast proportions by 2030, according to new World Health Organization projections, with many countries likely to see far more than half of adults above the healthy weight limit.
DAKAR - The U.N. envoy on Ebola on Tuesday hailed "extraordinary progress" against the outbreak in West Africa after new cases last week fell below 20 for the first time since mid-2014, but he warned it would take time to end the epidemic completely.
LONDON - European regulators do not agree with the negative view expressed by one adviser about the efficacy of UniQure's drug Glybera, the Western world's first gene therapy.
NEW YORK - The 2015 NFL Draft class has now been welcomed into the league, one that could grow safer as their careers unfold through new-age research into identifying concussions.
(Reuters Health) - Internet information about orthodontic braces varies in quality and may not be entirely accurate, according to a new study from the Netherlands.
NEW YORK - Fourteen U.S. and Canadian cancer institutes will use International Business Machines Corp's Watson computer system to choose therapies based on a tumor's genetic fingerprints, the company said on Tuesday, the latest step toward bringing personalized cancer treatments to more patients.
PARIS - The artificial heart fitted in a patient who died on Saturday malfunctioned due to a fault with the controls of its motor, but an initial analysis indicates there are no fundamental problems with the device, its manufacturer Carmat said in a statement.
CHICAGO - The U.S. government approved the use of an additional $330 million in emergency funds to help contain the worst avian influenza outbreak in U.S. history, as infected bird cases soared and hundreds of Minnesota poultry workers learned they would lose their jobs.